Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Genomics Research Asia

Andrei Thomas-Tikhonenko's Biography

Andrei Thomas-Tikhonenko, Professor, University of Pennsylvania

Dr. Andrei Thomas-Tikhonenko studied Biochemistry and Virology at Moscow State University and graduated with honors in 1984. He obtained his Ph.D. in Experimental Oncology in 1988 from the Russian Cancer Research Center in Moscow. He was postdoctoral Research Associate and then Staff Scientist at Fred Hutchinson Cancer Research Center in Seattle, WA. In 1997, he was recruited to the University of Pennsylvania, where currently he is tenured Associate Professor of Pathology & Laboratory Medicine and Chair of the Cancer Biology Graduate Program. He also serves as Chief of Division of Cancer Pathobiology and Mildred L. Roeckle Endowed Chair in Pathology at the Children's Hospital of Philadelphia. Dr. Thomas-Tikhonenko's research has been funded by multiple grants from the National Institutes of Health, Commonwealth of Pennsylvania, American Cancer Society, Leukemia Society of America, Swiss Cancer League, Alex's Lemonade Stand Foundation, The V Foundation, and WW Smith Charit
able Tr
ust. His past awards include Elizabeth & William Whitney Clark Developmental Chair in Oncology, Special Fellow of the Leukemia Society of America, and Fellow of the International Union Against Cancer (Geneva). He was the 2005 recipient of the Pfizer Award for Research Excellence. In 2008-2009 he served as Book Editor for "Cancer genome and tumor microenvironment" (Springer). His recent and current extramural activities include services as Permanent Member of the Tumor Progression and Metastasis Study Section (NIH), Member of Editorial Boards of Cancer Biology & Therapy (Landes Biosciences) and Cancer Microenvironment (Springer), and Associate Editor of Journal of Clinical Investigation.

Andrei Thomas-Tikhonenko Image

Tumor Type-specific Effects of Oncomir-1: Lessons from Mouse Models and Cancer Genomics

Wednesday, 13 November 2013 at 15:00

Add to Calendar ▼2013-11-13 15:00:002013-11-13 16:00:00Europe/LondonTumor Type-specific Effects of Oncomir-1: Lessons from Mouse Models and Cancer GenomicsGenomics Research Asia in

The miR-17-92 microRNA cluster was first identified as an oncogene by virtue of its amplification in a subset of human cancers. Yet while miR-17-92 is robustly transcribed in B-cell lymphoma, it maintains intermediate levels in most carcinomas, and is barely expressed in glioblastoma multiforme. This variance reflects fundamental differences in miR-17-92 biology across tumor types and has important implications for patient survival.

Add to Calendar ▼2013-11-12 00:00:002013-11-13 00:00:00Europe/LondonGenomics Research AsiaGenomics Research Asia in